Clinical Trials Directory

Trials / Terminated

TerminatedNCT01660009

Adverse Effects of Systemic Hypoglycemia Exposure on Endothelial Function in Humans

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
5 (actual)
Sponsor
Medical College of Wisconsin · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

Prior work suggests exposure to low glucose levels (hypoglycemia) is associated with increased cardiovascular risk. However, whether there is a causal relationship between cardiovascular events and hypoglycemia remains unclear with conflicting data in the literature. In this study, we plan to study whether acute exposure of patients to clinically relevant (50-60 milligrams/deciliter) levels of hypoglycemia induces or worsens blood vessel endothelial dysfunction- a key 1st step in the development of heart attacks and strokes. This will be determined in humans both with and with type 2 diabetes.

Conditions

Interventions

TypeNameDescription
OTHERGlycemic clampingDuring hypoglycemic clamping, individuals will have a blood glucose level of 50-60 mg/dL for approximately 1 hour prior to outcome measurements. During euglycemic clamping, individuals will have a blood glucose level of 85-99 mg/dL for approximately 1 hour prior to outcome measurements.

Timeline

Start date
2012-06-01
Primary completion
2017-06-01
Completion
2017-06-01
First posted
2012-08-08
Last updated
2017-08-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01660009. Inclusion in this directory is not an endorsement.